baber/WOPTO huggingface dataset:
Patent MX-2010011058-A (MX)
Title: Coffee extract.
Inventor: CAVIN CHRISTOPHE
IPC: A23F5/02
Filed: 2009-03-12
Abstract: The present invention relates to a method of producing a coffee extract with antioxidant and anti-inflammatory properties and uses of the extract of the invention. The coffee extract comprises caffeic acid and/or ferulic acid and can be produced by hydrolysing chlorogenic acids present in coffee extract, e.g. with a microorganism or an enzyme. The coffee extract of the invention may e.g. be used as an ingredient of a food or beverage product.
Patent MX-2010014533-A (MX)
Title: Method and apparatus for layer bonding of display assembly.
Inventor: SCHAPER PETER
IPC: G02F1/13
Filed: 2009-06-25
Abstract: A method and apparatus for the bonding of one or more material layers (106) to a display panel (102) which yields a resulting bonded assembly (100) which is transparent and substantially free of optical defects such as entrapped dirt and air bubbles. During the bonding process of the present disclosure, a moving dispensing probe, or needle (200), dispenses a liquid bonding material (110) into an air gap (300) between the surfaces to be bonded in a manner which continuously touches (wets) each surface simultaneously. By simultaneously wetting each surface, and by dispensing the liquid bonding material (110) in a predetermined pattern between the surfaces, the introduction of entrapped dirt and the formation of air bubbles is prevented as the two mating surfaces are subsequently pressed together and the adhesive is cured.
Patent MX-2011006077-A (MX)
Title: IgE CH3 PEPTIDE VACCINE.
Inventor: JONES LYN HOWARD
IPC: A61K39/00
Filed: 2009-12-04
Abstract: The present invention relates to the provision of immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
Patent MX-2011007716-A (MX)
Title: Automatic or machine dishwashing compositions of sulfonated estolides and other derivatives of fatty acids and uses thereof.
Inventor: BERNHARDT RANDAL J
IPC: C11D1/12
Filed: 2009-07-21
Abstract: Sulfo-estolides and methods of making them are described. Useful methods include acid side bleaching, partial hydrogenation of the fatty acid, pretreatment of the fatty acid to provide color inhibition, acid side hydrolysis of the sulfo-estolides, or conversion of SHP to an essentially fully hydrolyzed product (HSHP) or a partially hydrolyzed product (PHSHP). Formulations and concentrated formulations of automatic dishwasher detergent or machine wash detergent compositions containing sulfo-estolides, among others, are also included.
Patent MX-2011010218-A (MX)
Title: Autotaxin inhibitors.
Inventor: SCHIEMANN KAI
IPC: A61P35/00
Filed: 2010-03-09
Abstract: The present invention relates to compounds according to formula (I) as autotaxin inhibitors and the use of such compounds for the treatment and/or prophylaxis of physiological and/or pathophysiological conditions, which are caused, mediated and/or propagated by increased lysophosphatic acid levels and/or the activation of autotaxin, in particular of different cancers.
Patent MX-2012001955-A (MX)
Title: Surface modified pigment.
Inventor: HASKEL ARIEL
IPC: C09C3/10
Filed: 2009-08-31
Abstract: A composition comprising a pigment particle that is coated with a cationic material and isopropyI titanium triisostearate. The pigment particle can be included in a cleansing composition for deposition on a surface, such as skin.
Patent MX-2012002137-A (MX)
Title: Method for stereospecifically recycling a pla polymer mixture.
Inventor: COSZACH PHILIPPE
IPC: C07C67/03
Filed: 2010-07-19
Abstract: The present invention relates to a method for stereospecifically chemically recycling a polylactic acid (PLA) polymer mixture in order to reform the monomer thereof or one of the derivatives thereof. The latter can be used on the traditional lactate market or can be reused as raw material for PLA synthesis.
Patent MX-2012006472-A (MX)
Title: Rodent bait packed in a biodegradable foil.
Inventor: HOYOS MARCELO
IPC: A01N43/16
Filed: 2010-12-09
Abstract: The present invention relates to a bait system comprising a rodent bait, which is packed in a biodegradable foil containing polyester and starch. The present invention also relates to a method for controlling rodents, comprising the steps of a) packing said rodent bait in said biodegradable foil, and b) offering the packed bait to rodents. It also relates to a bait system comprising, as separate components, a) said rodent bait, and b) said biodegradable,for combined use in controlling rodents.
Patent MX-2012011998-A (MX)
Title: A process and system for manufacturing a roller blind.
Inventor: COLSON WENDELL B
IPC: B32B37/06
Filed: 2011-04-15
Abstract: A process and system for manufacturing roller blinds is provided which includes structure for performing plural steps including a first step of helically winding slat fabric about a drum, thereby forming a slat product. A second step includes moving the slat product from the drum to a platform. A third step includes winding the slat product about a roller tube to form a roller blind. A fourth step includes moving the blind from the platform to a heat treating device.
Patent MX-2012012110-A (MX)
Title: Assembly and method for reducing nitrogen oxides, carbon monoxide and hydrocarbons in exhausts of internal combustion engines.
Inventor: GEHRET JOSEPH B
IPC: F01N3/00
Filed: 2010-10-28
Abstract: An assembly and method for reducing nitrogen oxides, carbon monoxide and hydrocarbons in exhausts of internal combustion engines, wherein the exhaust is acted upon in a first stage catalytic converter. A first portion of the first stage catalytic converter output is cooled and a second portion of the catalytic converter output is not cooled. The cooled and not cooled exhausts are united and directed to a second stage catalytic converter. Air is injected into a selected one of (1) the not cooled exhaust prior to the juncture thereof with the cooled exhaust, and (2) the combined cooled and not cooled exhausts after the juncture thereof.
Patent MX-2012012760-A (MX)
Title: Method for the activation of a windscreen wiper motor.
Inventor: HOEGLER EBERHARD
IPC: B60S1/02
Filed: 2012-10-31
Abstract: The invention relates to a method for the activation of a windscreen wiper motor (20), in which the windscreen wiper motor (20) is connected via a drive shaft (21) at least indirectly with at least one wiper blade (11, 12), which moves the at least one wiper blade (11, 12) to and fro between two reversal points (UP, OP) of a wiping field (26) in differing movement direction, wherein the rotation speed and the rotation direction of the windscreen wiper motor (20) or respectively the speed (v) of the at least one wiper blade (11, 12) is detected by means of a sensor device (22) and is supplied to a control device (25) as an input value, and wherein the windscreen wiper motor (20) before reaching the respective reversal point (UP, OP) is switched off at a switch-off time (ASZ), whereupon the drive shaft (21) of the windscreen wiper motor (20); continues to rotate further by a castor angle (+-) up to its standstill, and the at least one wiper blade (11, 12) continues to move further by a trailing distance (NLS). It is provided according to the invention that the actual speed (V ist ) of the at least one wiper blade (11, 12) is compared at the switch-off time (ASZ) with a nominal speed (V soll ), and that with a difference between the actual value from the nominal value, the windscreen wiper motor (20) is operated further for a period of time ( T) which is defined in the control device (25).
Patent MX-2012012812-A (MX)
Title: Double-flow solar collector.
Inventor: FOLGUERAS JOSE RODRIGO SALMON
IPC: F24J2/00
Filed: 2012-11-01
Abstract: The present patent application is intended to provide a double-flow solar collector The invention includes a first and a second tube grid, where the tubes are attached by one end portion thereof to a shared head, so that the tubes of the first and second grid are interlaced and present the same length, the tubes of the first grid being connected by the free end portion to a first head, and the tubes of the second grid being connected by the free end portion to a second head, both being arranged in a parallel relationship and aligned therebetween; a metallic wavy reflecting plate is arranged between the grids, so that the tubes of the first grid are directed towards the upper waves of the first wavy plate and the tubes of the second grid are directed towards the lower waves of the first wavy plate; the first head has a water inlet resulting from a storing tank and as many orifices as tubes in the first grid and aligned therewith, the shared head having as many inlet orifices as tubes i n the first grid and as many outlet orifices as tubes in the second grid, and the second head comprising as many inlet orifices as tubes in the second grid, and an outlet leading to a water inlet in the storing tank.
Patent MX-2013003918-A (MX)
Title: Benzimidazole derivatives as pi3 kinase inhibitors.
Inventor: QU JUNYA
IPC: A01N43/52
Filed: 2011-09-23
Abstract: This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3' OH kinase family (hereinafter PI3 kinases), suitably, PI3KÎ±, PI3KÎ´, PI3KÎ², and/or PI3KÎ³. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3KÎ² selective benzimidazoles compounds for treating cancer.
Patent MX-2013005047-A (MX)
Title: A new variant of antihemophilic factor viii having increased specific activity.
Inventor: LAI CHEE KONG
IPC: A61K35/14
Filed: 2011-11-04
Abstract: The present invention is in the field of hemophilia therapy. It relates to a new variant of antihemophilic factor VIII having increased specific activity in comparison to known factor VIII products.
Patent MX-2013006632-A (MX)
Title: Sargassum buxifolium extract for the treatment of cervicouterine cancer.
Inventor: CORONA ROSALVA RANGEL
IPC: A61K36/02
Filed: 2013-06-12
Abstract: The present invention describes the process for obtaining and using the Sargassum buxifolium extract. The invention describes the process for obtaining the extract of SaBu from organic solvents, alone or combined; the concentrate and further fractioning thereof by column chromatography. The tests performed to the extract of Sargassum buxifolium shown that this alga has antiproliferative and apoptosis induction properties over the cells of cervicouterine cancer (CALO AND INBL). The present invention describes the use of the Sargassum buxifolium extract as an immunoregulatory agent in lymphocytes of peripheral blood.
Patent MX-2013007054-A (MX)
Title: Methods for pretreating biomass.
Inventor: DALE BRUCE E
IPC: C07H99/00
Filed: 2011-12-22
Abstract: A method for treating biomass is provided, which includes, in a reactor, allowing gaseous ammonia to condense on the biomass and react with water present in the biomass to produce pretreated biomass, wherein reactivity of polysaccharides in the biomass is increased during subsequent biological conversion as compared to polysaccharides in biomass which has not been pretreated. A method for treating biomass with a liquid ammonia and recovering the liquid ammonia is also provided. Related systems which include a biochemical or biofuel production facility are disclosed.
Patent MX-2013010203-A (MX)
Title: Chromene compound.
Inventor: MOMODA JUNJI
IPC: C09K9/02
Filed: 2012-03-07
Abstract: The present invention provides a novel photochromic compound having superior durability, a rapid fading speed, and a high color-emission density, and wherein the color tone during color emission exhibits an intermediate color. The chromene compound is characterized by a heterocyclic ring having two heteroatoms including at least one sulfur atom that is directly bonded to the hetero atom at the 6th position and 7th position of an indeno(2,1-f)naphtho(1,2-b)pyrane structure, and having the indeno(2,1-f)naphtho(1,2-b)pyrane structure as the basic framework such as the compound indicated by the formula (18), for example.
Patent MX-2013010463-A (MX)
Title: Multi-layer body.
Inventor: TOMPKIN WAYNE ROBERT
IPC: B42D15/00
Filed: 2012-03-07
Abstract: The invention relates to a multi-layer body (10) and to a process for the production thereof. The multi-layer body has a first layer (23) with a first surface (231) and a second surface (232) lying opposite the first surface (231). The first surface (231) of the first layer (23) is defined by a base plane spanned by coordinate axes x and y, wherein a large number of facet faces (50) are moulded into the second surface (232) of the first layer (23) in a first region (31). Each of the facet faces (50) is determined by one or more of the parameters F, S, H, P, Ax, Ay and Az, wherein the parameters of the facet faces (50) arranged in the first region (31) are varied, in the first region (31), pseudorandomly within a variation range predefined in each case for the first face region, and wherein a reflective, second layer (24) is applied to each of the facet faces.
Patent MX-2013011971-A (MX)
Title: Treatment of disease with poly-n-acety glucosamine nanofibers.
Inventor: FINKIELSZTEIN SERGIO
IPC: A01N43/04
Filed: 2012-04-16
Abstract: This application relates to compositions comprising shortened fibers of poly-N- acetylglucosamine and/or a derivative thereof ("sNAG nanofibers") and the use of such compositions in the treatment of disease.
Patent MX-2013014105-A (MX)
Title: Disposable absorbent garment having colored facings and integral waistband.
Inventor: POOLE LACEY L
IPC: A61F13/62
Filed: 2012-05-23
Abstract: A garment comprises a laminate. The laminate comprises a first layer colored a first color, and a second layer colored a second color different than the first color. The laminate includes a folded flap in the waist region, thereby defining an integral, outwardly visible waistband having a waistband lower edge. In one embodiment, the first layer and the second layer are coterminous at the waistband lower edge. In particular embodiments, the folded flap is an outwardly folded flap, and the first layer is an inner layer and the second layer is an outer layer, and the outwardly visible waistband is colored the first color. The distinction between the first color and second color in conjunction with the fold creates a visible waistband effect.
Patent MX-2013014210-A (MX)
Title: Antibodies specific for tgf-beta.
Inventor: BEDINGER DANIEL
IPC: C07K16/22
Filed: 2012-06-01
Abstract: The present disclosure relates, in general, to materials and methods for antibodies specific for transforming growth factor beta (TGFPÎ²), including TGFÎ²1, TGFÎ²2 and TGFÎ²3, and uses of these antibodies in the treatment of subjects having cancer, an eye disease, condition or disorder, fibrosis, including ophthalmic fibrosis or fibrosis of the eye, and other conditions or disorders related to TGFÎ² expression.
Patent MX-2013014907-A (MX)
Title: Storing multiple instances of content.
Inventor: KENNEDY JOHN T
IPC: H04N7/167
Filed: 2012-08-23
Abstract: Content receivers may simultaneously record multiple instances of content for multiple programming channels based on content provider instructions. Systems and methods utilize the content receivers to record these multiple instances from at least a single transponder. In some instances, multiple transponders may have a common control word so that content carried on each such transponder may be simultaneously received, decoded and recorded. Further, a single demodulator may be associated with multiple tuners, so that the single demodulator processes all content received from transponders with common control words and/or other encryption mechanisms.
Patent MX-2014001118-A (MX)
Title: Alloyed hot-dip zinc coat layer, steel sheet having same, and method for producing same.
Inventor: YASUI TAKESHI
IPC: C23C2/28
Filed: 2012-07-27
Abstract: Provided are: an alloyed hot-dip zinc-coated steel sheet that, as an alloyed hot dip zinc-coated steel sheet that uses a high-strength steel sheet as the parent material, reliably and sufficiently increases the adhesion of the coating layer to the parent material steel sheet; and a method for producing the alloyed hot-dip zinc-coated steel sheet. An alloyed hot-dip zinc coat layer is formed on a parent material steel sheet comprising high-strength steel having a predetermined component composition, the average amount of Fe in the alloyed hot-dip zinc coat layer is in the range of 8.0-12.0%, and, in the coating layer, the absolute value (ÎFe) of the difference between the amount of Fe (inner vicinity amount of Fe) at the vicinity of the interface with the parent material steel sheet and the amount of Fe (outer vicinity amount of Fe) at the vicinity of the outer surface of the coating layer is in the range of 0.0-3.0%. Also, as a method for producing same, after the completion of hot dip zinc coating and alloying processing, coating layer inner diffusion processing is performed to flatten the Fe concentration gradient in the coating layer.
Patent MX-2014001627-A (MX)
Title: Novel anti-human ngf antibody.
Inventor: KAMOHARA MASAZUMI
IPC: C12N1/21
Filed: 2012-08-10
Abstract: [Problem] To provide: an anti-human NGF antibody which is reduced in the influence on fetuses and the risk of adverse side effects including thrombosis while keeping a high neutralizing activity, and which has excellent safety, or an antigen-binding fragment thereof; and a means for preventing or treating various diseases for which human NGF is involved in the development of a disease state, which utilizes the antibody or an antigen-binding fragment thereof. [Solution] An Fab' fragment of an anti-human NGF antibody, which comprises a heavy-chain variable region comprising the amino acid sequence represented by SEQ ID NO: 6 and a light-chain variable region comprising the amino acid sequence represented by SEQ ID NO: 4.
Patent MX-2014003318-A (MX)
Title: Endogenous dnase activity to reduce dna content.
Inventor: HOFFMANN KATHERINE
IPC: C12P21/02
Filed: 2012-09-20
Abstract: The application provides a method of reducing the DNA content of a protein preparation or a culture broth from a filamentous fungal host cell using an endogenous filamentous fungal host DNase activity.
Patent MX-2014004338-A (MX)
Title: Hydraulic fracturing with proppant pulsing through clustered abrasive perforations.
Inventor: PENA ALEJANDRO
IPC: E21B43/11
Filed: 2012-10-11
Abstract: Well completion techniques are disclosed that combine the creation of perforation clusters created using abrasive-jet perforation techniques with hydraulic fracturing techniques that include proppant pulsing through the clustered abrasive jet perforations. Both the abrasive-jet perforation and hydraulic fracturing with proppant pulsing may be carried out through coiled tubing.
Patent MX-2014004996-A (MX)
Title: Resins of b-hydroxy propyl gamma-polyoxyalkylene ethers and polymers thereof.
Inventor: WEINSTEIN BARRY
IPC: C08F220/28
Filed: 2012-10-25
Abstract: The present invention provides aqueous compositions comprising Ã-hydroxy propyl gamma-polyoxyalkylene ether functional resins chosen from (poly)oxyalkylene ether Ã-hydroxy propyl (meth)acrylates, maleates and itaconates, water soluble copolymers thereof, and mixtures thereof. The water soluble copolymers are comb polymers and (meth)acrylate, maleate and itaconate monomer resins can be addition polymerized to form comb polymers suitable for many uses, such as superplasticizers, dispersants, detergents and floor care compositions. In addition, the present invention provides methods of making the resins by reacting in water or aqueous solvent one or more reactant a) a glycidyl polyether or glycidyl ether, optionally having an alkyl or aryl end group with one or more reactant b) a carboxylate anion containing vinyl compound or polymer, preferably a polymer such as poly(meth)acrylic acid. The methods enable simple formation of comb polymers.
Patent MX-2014005845-A (MX)
Title: Preventing flow of undesired fluid through a variable flow resistance system in a well.
Inventor: GRECI STEPHEN M
IPC: E21B34/06
Filed: 2011-11-14
Abstract: A flow control system for use with a subterranean well can include a flow chamber through which a fluid composition flows, and a closure device which is biased toward a closed position in which the closure device prevents flow through the flow chamber. The closure device can be displaced to the closed position in response to an increase in a ratio of undesired fluid to desired fluid in the fluid composition. A structure can prevent the closure device from being displaced to the closed position. The fluid composition can flow through the structure to an outlet of the flow chamber.
Patent MX-2014007709-A (MX)
Title: Transverse adjustable laser beam restrictor.
Inventor: KARAVITIS MICHAEL
IPC: G02B26/08
Filed: 2012-12-19
Abstract: A laser adjustment system can include an adjustable seed-beam restrictor (230), configured to be attachable to a stretcher-compressor (200) in a transverse-adjustable manner, and to restrict an incidence of a seed beam (101), generated by an oscillator (100), on the stretcher-compressor (200), wherein the stretcher-compressor (200) is configured to be integrated into a chirped pulse amplification laser engine (1), and to stretch a duration of seed pulses (lOlp) of the seed beam (101).
Patent MX-2014010106-A (MX)
Title: Topical compositions comprising fipronil and permethrin and methods of use.
Inventor: SOLL MARK DAVID
IPC: A61K47/14
Filed: 2013-02-22
Abstract: The subject matter disclosed herein is directed to stable, highly-effective topical formulations comprising permethrin, fipronil and a solvent system that is sufficient to solubilize these two active ingredients and limit degradation of fipronil to its sulfone, and their uses in topical applications on animals and the environment. Useful formulations comprise from about 30 % to about 55 % (w/w) permethrin and about 2 to 15 % (w/w) fipronil and a solvent system that comprises N-methyl pyrrolidone and a glycol, glycol ether, glycol ester, fatty acid ester or neutral oil, wherein the N-methyl pyrrolidone and glycol, glycol ether, glycol ester, fatty acid ester or neutral oil are present in a weight : weight ratio of from about 1 :2.0 to about 1 :3.5, glycol, glycol ether, glycol ester, fatty acid ester or neutral oil to n-methyl pyrrolidone. These two actives when combined in the described amounts have been found to have unexpected enhanced repellent activity against stable fly. However, it is the formulations described herein that provide solvency and stability that maintain synergistic concentrations after application on an animal.
Patent MX-2014015826-A (MX)
Title: Method for predicting response in a standard treatment of locally advanced cervical cancer.
Inventor: PLASENCIA CARLOS PÉREZ
IPC: C12Q1/68
Filed: 2014-12-18
Abstract: The present disclosure is related to useful methods to predict if a patient diagnosed with locally advanced cervical cancer, could present a good or a poor response to standard treatment. Methods are based on the determination of the gene expression profile of a signature comprising the genes: ZNF238; SAP30; C10orf137; UHRF1; SUZ12; HMGN4; RBBP4; ARID1B; PPP1CB; SLFN11; FLJ39378; ENDOGL1; RECQL; TRPC1; TRIO; DNAH6; GNL3L; SLC36A2; SRP9; RPE; LDOC1L; PUS7L; CCDC89; LOC644921; PLEKHG1; FAM11B; RPRD2 and ETAA16 and its comparison with type expression profiles.